Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
1-Year Return
7.86%
This Quarter Return
+5.95%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$16.6B
AUM Growth
+$951M
(+6.1%)
Cap. Flow
+$96.2M
Cap. Flow
% of AUM
0.58%
Top 10 Holdings %
Top 10 Hldgs %
7.86%
Holding
3,168
New
755
Increased
828
Reduced
689
Closed
831
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$104M |
| 2 |
Goldman Sachs
GS
|
+$103M |
| 3 |
Steel Dynamics
STLD
|
+$101M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$95.5M |
| 5 |
PepsiCo
PEP
|
+$95.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$145M |
| 2 |
Exxon Mobil
XOM
|
+$141M |
| 3 |
Microsoft
MSFT
|
+$140M |
| 4 |
Coca-Cola
KO
|
+$140M |
| 5 |
Broadcom
AVGO
|
+$129M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Industrials | 13.07% |
| 3 | Consumer Discretionary | 12.98% |
| 4 | Healthcare | 12.98% |
| 5 | Financials | 12.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
CBIZ
CBZ
$3.01B
| $2.7M | 0.01% |
57,541
+15,576
| +37% | +$730K |
|
777
Telkom Indonesia
TLK
$19B
| $2.69M | 0.01% |
112,987
+27,148
| +32% | +$647K |
|
|
DCPH
778
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.69M | 0.01% |
164,226
+42,710
| +35% | +$700K |
|
779
O'Reilly Automotive
ORLY
$89.2B
| $2.69M | 0.01% |
47,745
-771,750
| -94% | -$43.4M |
|
780
Brady Corp
BRC
$3.69B
| $2.68M | 0.01% |
57,000
+41,328
| +264% | +$1.95M |
|
781
Northwest Bancshares
NWBI
$1.83B
| $2.68M | 0.01% |
191,464
+164,870
| +620% | +$2.3M |
|
782
Marriott International Class A Common Stock
MAR
$71.2B
| $2.68M | 0.01% |
+17,975
| New | +$2.68M |
|
783
Revolve Group
RVLV
$1.67B
| $2.67M | 0.01% |
119,828
+109,790
| +1,094% | +$2.44M |
|
784
Premier
PINC
$2.21B
| $2.67M | 0.01% |
76,240
-287,417
| -79% | -$10.1M |
|
785
Taylor Morrison
TMHC
$6.89B
| $2.66M | 0.01% |
87,661
+20,956
| +31% | +$636K |
|
786
iShares MSCI Canada ETF
EWC
$3.25B
| $2.65M | 0.01% |
80,853
+55,056
| +213% | +$1.8M |
|
787
Axcelis
ACLS
$2.62B
| $2.64M | 0.01% |
33,222
-6,606
| -17% | -$524K |
|
|
RVNC
788
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.62M | 0.01% |
141,880
+113,211
| +395% | +$2.09M |
|
789
AbCellera Biologics
ABCL
$1.28B
| $2.62M | 0.01% |
258,517
+206,750
| +399% | +$2.09M |
|
790
Laureate Education
LAUR
$4.09B
| $2.62M | 0.01% |
+271,875
| New | +$2.62M |
|
791
ICF International
ICFI
$1.77B
| $2.61M | 0.01% |
+26,354
| New | +$2.61M |
|
792
Pebblebrook Hotel Trust
PEB
$1.36B
| $2.6M | 0.01% |
194,193
+167,065
| +616% | +$2.24M |
|
793
Sun Communities
SUI
$16.1B
| $2.59M | 0.01% |
18,132
-208,259
| -92% | -$29.8M |
|
794
Eletrobras Common Shares
EBR
$19.1B
| $2.59M | 0.01% |
326,725
-39,334
| -11% | -$312K |
|
795
Veracyte
VCYT
$2.42B
| $2.58M | 0.01% |
108,772
-38,487
| -26% | -$913K |
|
796
Fresenius Medical Care
FMS
$14.6B
| $2.58M | 0.01% |
157,868
+4,094
| +3% | +$66.9K |
|
797
TG Therapeutics
TGTX
$5.05B
| $2.55M | 0.01% |
215,527
+60,206
| +39% | +$712K |
|
|
XM
798
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $2.54M | 0.01% |
244,609
+174,139
| +247% | +$1.81M |
|
|
VMW
799
DELISTED
VMware, Inc
VMW
| $2.53M | 0.01% |
20,642
-124,216
| -86% | -$15.2M |
|
800
Vanguard Dividend Appreciation ETF
VIG
$97B
| $2.53M | 0.01% |
16,687
+5,693
| +52% | +$864K |
|